Piperazine derivatives useful as CCR5 antagonists
A Standard patent application filed on 01 May 2000 credited to Baroudy, Bahige M
;
Labroli, Marc A.
;
Josien, Hubert B.
;
McCombie, Stuart W.
;
McKittrick, Brian A.
;
Miller, Michael W.
;
Neustadt, Bernard R.
;
Palani, Anandan
;
Smith, Elizabeth M.
;
Steensma, Ruo
;
Tagat, Jayaram R.
Details
Application number :
45009
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Piperazine derivatives useful as CCR5 antagonists
Inventor :
Baroudy, Bahige M
;
Labroli, Marc A.
;
Josien, Hubert B.
;
McCombie, Stuart W.
;
McKittrick, Brian A.
;
Miller, Michael W.
;
Neustadt, Bernard R.
;
Palani, Anandan
;
Smith, Elizabeth M.
;
Steensma, Ruo
;
Tagat, Jayaram R.
Agent name :
Griffith Hack
Address for service :
GPO Box 4164 SYDNEY NSW 2001
Filing date :
01 May 2000
Associated companies :
Applicant name :
Schering Corporation
Applicant address :
2000 Galloping Hill Road Kenilworth NJ 07033-0530 United States Of America